This will change quickly as the issues are resolved and the results are moved into the Decisions Log:
9d36cb32-4900-4aa7-ad23-3900e6476118DECIDED1b5ed5cb-5a4c-4d30-8ded-fda6ba17694aShould we answer ALL 14 high-priority questions in the pilot project to call the pilot a success? If not, which questions to focus on? Or what % of questions are enough for success?DECIDED952ffff4-87e5-4119-9b7c-305763bd5fe8Is the list of terms that we want to supplement the existing terms/ontologies with final? Can we iteratively add terms as we create annotations in case we miss some in the early analysis?DECIDED58195c8b-1534-4389-886a-f791666f18f4Need to define the process for quality control (QC) in both full project and in the pilot. In the pilot, would a systematic random sample of 1% of assays be sufficient for QC?DECIDEDdd1d45a9-3fa4-41a8-a40c-b147e39fad8aWhat conditions must assay annotations meet to be considered finished and ready for release?DECIDED98bf4541-f2e6-4d87-a2b4-568395e45f9bNeed the definite list of assays that would be used in the pilot. What about an iterative approach for naming of assays?DECIDED6f251149-0c94-4c9a-8233-1f19f64d1f87Need to agree on the process for naming of assays for annotation in the full-scale projectDECIDEDfdd09a30-62ba-44ce-9c87-cdecc60fffa0Technical ability, prices, terms and conditions for annotation vendors are not fully knownDECIDED9ff93034-5b75-4a31-ab93-2d7e16611a42Technical conditions for deposition of enhanced assay annotations into ChEMBL are not knownDECIDED3b32ef3d-20e3-403f-b825-ed8102d60f21Other external groups (e.g. Medicines Discovery Catapult, Druggable Genome Project, Medicines for Malaria) are not yet engaged, and the scope of such potential engagement is not knownDECIDEDcec10982-55d1-4ee7-81f1-1c5b427590aeAbout 90% of papers with assay descriptions are not in open access. Hence, we would need to negotiate with publishers.DECIDED836c57bc-bfae-49a1-b93b-8ca47a962f1aIn the papers that are formally associated with assays in public data banks like ChEMBL and PubChem, in reality the assay annotations may be missing, or be extremely shallow, or be references to other papers or commercial assay kits.a99480e6-4b2a-4f22-b7ab-d36f368fd312DECIDEDAnnotation labor is much more expensive than initially expected. Solution: open RFP for labor services400ba64c-50a4-4f70-8fcb-4b4d687f7540DECIDEDDespite 1.5 million assay records in PubChem, we are failing to quickly nominate interesting assays to annotate, and this leads to delays in the project394838c7-2e59-4054-9d65-01cfa5964880DECIDEDProcess for upload of assays in PubChem is very slow. Solution: ask PubChem about options to format the assay metadata in order to avoid having to re-format from the already available formats- Should we answer ALL 14 high-priority questions in the pilot project to call the pilot a success? If not, which questions to focus on? Or what % of questions are enough for success?
- Is the list of terms that we want to supplement the existing terms/ontologies with final? Can we iteratively add terms as we create annotations in case we miss some in the early analysis?
- Need to define the process for quality control (QC) in both full project and in the pilot. In the pilot, would a systematic random sample of 1% of assays be sufficient for QC?
- What conditions must assay annotations meet to be considered finished and ready for release?
- Need the definite list of assays that would be used in the pilot. What about an iterative approach for naming of assays?
- Need to agree on the process for naming of assays for annotation in the full-scale project
- Technical ability, prices, terms and conditions for annotation vendors are not fully known
- Technical conditions for deposition of enhanced assay annotations into ChEMBL are not known
- Other external groups (e.g. Medicines Discovery Catapult, Druggable Genome Project, Medicines for Malaria) are not yet engaged, and the scope of such potential engagement is not known
- About 90% of papers with assay descriptions are not in open access. Hence, we would need to negotiate with publishers.
- In the papers that are formally associated with assays in public data banks like ChEMBL and PubChem, in reality the assay annotations may be missing, or be extremely shallow, or be references to other papers or commercial assay kits.
- Annotation labor is much more expensive than initially expected. Solution: open RFP for labor services
- Despite 1.5 million assay records in PubChem, we are failing to quickly nominate interesting assays to annotate, and this leads to delays in the project
- Process for upload of assays in PubChem is very slow. Solution: ask PubChem about options to format the assay metadata in order to avoid having to re-format from the already available formats